Denosumab for post-transplantation hypercalcemia in osteopetrosis

N Engl J Med. 2012 Nov 1;367(18):1766-7. doi: 10.1056/NEJMc1206193.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Child
  • Child, Preschool
  • Denosumab
  • Fatal Outcome
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Hypercalcemia / drug therapy*
  • Hypercalcemia / etiology
  • Osteopetrosis / therapy*
  • RANK Ligand / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal, Humanized
  • RANK Ligand
  • TNFSF11 protein, human
  • Denosumab